Thursday, October 23, 2014

18:30-19:30
OPENING SESSION 
Chairpersons
Carolyn Henry, USA
Phil Bergman, USA

18:30

Welcome Greetings
Carolyn Henry, USA; Phil Bergman, USA

18:40

Plenary Talk: How veterinarians will transform the future of human medicine
Barbara Natterson-Horowitz, USA
 

19:30-20:30

Welcome reception

Friday, October 24, 2014

08:30-10:00
ONE HEALTH IMPLICATIONS FOR TB ACROSS SPECIES (Hall A)

Chairperson

Alasdair J.C. Cook, UK

08:30

Controversies in control of TB in humans and animals
Alasdair J.C. Cook, UK

08:50

One health implications of MTB complex across species
Carole McArthur, USA

09:10

Overview and phylogeny of Mycobacterium tuberculosis complex organisms: Implications for diagnostics and legislation of bovine tuberculosis
Sabrina Rodriguez-Camposa, Switzerland

09:30

Discussion

 

08:30-10:30

ONCOLOGY I (Hall B)

Chairpersons

Carolyn Henry, USA
Jeff Bryan, USA
 08:30
Debate: When is it appropriate to use various assays and molecular methods to screen for, classify, or confirm a diagnosis of lymphoma?
 
Academic view: Luca Aresu, Italy
Private practice and commerical lab view: Phil Bergman, USA
Biotech View: Tariq Shah, USA
Practical application of novel biomarkers: Jeff Bryan, USA
 

Discussion
10:00 - 10:20 Coffee Break 

10:20-11:50

STRATEGIES FOR DEALING WITH EMERGING PATHOGENS (Hall A)

Chairperson

Andrew Waller, UK
Alasdair J.C. Cook, UK                                
 10:20
Debate: Different options for the vaccination of horses against strangles, influenza and EHV
 
Prevention of strangles and EHV infection - strategies to eradicate or vaccinate: Andrew Waller, UK
Strategies for the prevention and control of equine influenza: Anne Cullinane, Ireland 
 
Discussion
11:30
Novel vaccination strategies for the control of African horse sickness
Javier Castillo-Olivares, UK
11:50-12:10 Poster viewing

 

10:20-11:50
ONCOLOGY II (Hall B)

Chairperson

Jeff Bryan, USA

10:20

Just because we can, doesn't necessarily mean we should
Carolyn Henry, USA

10:40

Veterinary cancer immunotherapy: Hype or reality?
Phil Bergman, USA

11:00

Metronomic therapy: Hype or hope?
Jeff Bryan, USA

11:20

Discussion

 

12:10-13:40
CONTROVERSIES IN VACCINE STRATEGIES (Hall A)

Chairperson

Daniel Elad, Israel

12:10

Vaccination of small animals
Trevor Waner, Israel

12:30

Adjuvants and feline vaccine-associated sarcoma - reality or myth?
Phil Bergman, USA

12:50

Escherichia coli mastitis; strains vs. host-related factors paradigm
Gabriel Leitner, Israel

13:10

Discussion 

 

14:30-16:00

ORTHOPAEDICS I: STEM CELLS - DO THEY WORK AND IF SO, HOW AND FOR WHAT? (Hall A)

Chairperson

Andras Dinnyés, Hungary
14:30
Debate: The limitations of MSC's and the falsely perceived "no risk" nature of MSC's vs. Pluripotent stem cell based methods potential
 
Induced pluripotent stem cells (iPS): Andras Dinnyés, Hungary
MSC's - are they safe and are they effective?: Jame Cook, USA

Discussion

15:40

Chondroprogenitors - are they the safest option for cartilage repair?                             
Ali Mobasheri
, UK
           
16:00-16:30 Coffee Break

16:30-18:00
ORTHOPAEDICS II: WHAT DO I DO CURRENTLY? (Hall A)

Chairperson

James Cook, USA

16:30

Nutraceuticals for joint health and osteoarthritis biomarkers
Yves Henrotin, Belgium

16:50

Use of biologics in veterinary orthopaedics
James Cook, USA

17:10

What can we learn from synovial fluid to improve osteoarthritis diagnosis and treatment?
Caroline Boulocher, France

17:30

Discussion

 

Saturday, October 25, 2014

08:30-10:00
INFLAMMATION AND BIOMARKERS (Hall A)

Chairperson

David Eckersall, UK 

08:30

Systemic biomarkers: How can they help with stratification?
David Eckersall, UK

08:50

Biomarkers of prognosis and efficacy of treatment in OA
Yves Henrotin, Belgium

09:10

Biomarkers of infectious disease and their value in detection and monitoring treatment 
Jose Ceron, Spain

09:30

Discussion

10:00

Coffee Break

 

08:30-10:00
HEARTWORM DISEASE AND CARDIOMYOPATHY (Hall B)

Chairperson

Claudio Genchi, Italy 

08:30

One health, the case of Dirofilaria infections in animals and humans
Claudio Genchi, Italy

08:50

Feline heartworm disease
Luigi Venco, Italy

09:10

Discussion: The potential for human infection
Claudio Genchi, Italy
Luigi Venco, Italy

09:30

Audience Discussion

 

10:20-11:50

ANTIBIOTIC RESISTANCE (Hall A)

Chairperson

Daniel Elad, Israel
 10:20
Debate: Is bacterial susceptibility to antimicrobials really changing?
 
When bacteria don’t follow the antimicrobial susceptibility rulebook: Daniel Elad, Israel
The development of novel intervention strategies for controlling Brachyspira in poultry: Roberto Marcello La Ragione, UK
 
Discussion
11:20
The emergence of multidrug-resistant bacteria in animals: public health and animal implications
Luca Guardabassi, Denmark

10:20-11:50
FREE COMMUNICATIONS (Hall B)

Chairperson

Ali Mobasheri, UK

10:20

EPIDEMIOLOGICAL AND ECONOMIC MODELLING STUDY DEMONSTRATING THE POTENTIAL OF ANTIVIRAL AGENTS TO CONTROL CLASSICAL SWINE FEVER OUTBREAKS
Robert Vrancken, Belgium 

10:30

IS CHLAMYDIA PSITTACI A PRIMARY PATHOGEN OF AVIAN HOSTS?
Avishai Lublin, Israel 
10:40

PREDICTION IS DIFFICULT, PREPARATION IS CRITICAL AND POSSIBLE                          
Romano Zilli, Italy

10:50 EFFECT OF HAY FEEDING ON PH AND VOLATILE FATTY ACIDS (VFA) IN THE RUMINAL FLUID OF HOLSTEIN CALVES AT WEANING
Sato Shigeru, Japan 
11:00 STUDY OF P53 DOMAIN MUTATION IN OVINE PULMONARY ADENOMATOSIS
Pejman Mortazavi, Iran 
11:10 A NOVEL POLYHERBAL FORMULATION WITH ANTI ULCER-ANTIARTHRITIC ACTIVITY
Chandana Choudhury Barua, India 
 11:20 Clinical treatment of OA: NSAIDs, nutraceuticals and stem cells: What does the research-informed practitioner want to know?

John Reilly, UK

11:30 CREATING AND TESTING THE MOBILE DIAGNOSTIC SYSTEM FOR MASTITIS
Claire Heffernan, UK
11:40 CONTROVERSIES AND IMPACTS: CREATING THE ONE HEALTH METRIC
Claire Heffernan, UK

 

12:10-13:40

EARLY SPAY/NEUTER - A CAUSE FOR CONCERN (Hall A)

Chairperson

Phillip Bergman, USA
12:10
Debate: Association vs. causation
 
Pro: Early spay/neuter side for cancer: Phillip Bergman, USA
Anti: Early spay/neuter side for cancer: Iris M. Reichler, Switzerland

Discussion
13:10
Anti early spay/neuter side for non-cancerous diseases
Iris M. Reichler, Switzerland
13:30 Discussion/Q&A
13:40-14:30 Lunch Break 

14:30-16:00
CONTROVERSIES REGARDING VECTOR-BORNE DISEASES AND PARASITIC INFECTIONS (Hall A)

Chairperson

Claudio Genchi, Italy

14:30

Why Dirofilaria repens has more zoonotic impact than Dirofilaria immitis?
Claudio Genchi, Italy

14:50

Feline intestinal parasites and vector-borne diseases
Chris Adolph, USA

15:10

Is treatment of healthy dogs with positive serologic Ehrlichia titers warranted? 
Leah Cohn, USA

15:30

Vector-borne disease: A One Health perspective 
Alasdair J.C. Cook, UK

15:50

Discussion 

 

16:30-17:30

CONTROVERSIES IN COLIC MANAGEMENT (Hall A)

Chairperson

Amir Steinman, Israel
 
Debate: The recovery of injury in horses after general anesthesia: The use and abuse of antibiotics for colic patients
16:30
Antimicrobial use in surgical colic patients – are we doing enough to  prevent resistance?
Amir Steinman, 
Israel
16:45
Should we use 1% sodium carboxymethylcellulose intraoperatively for  abdominal adhesion prevention? 
Amos Tatz,
Israel
17:00
Post-operative pain management in colic patients: Are we doing enough?                                
Jarred Williams,
USA
17:15
Audience Discussion

17:30-18:00
KEYNOTE SPEAKER (Hall A)

17:30

Excitability of cancer cells in the metastatic process: Novel anticancer targets?
Mustafa B.A. Djamgoz, UK